Vaccine, AstraZeneca, Tesla, Regeneron: 5 Things You Must Know

Here are five things you must know for Monday, Nov. 23:

1. — Stock Futures Rise on Vaccine Progress

Stock futures rose Monday as investors welcomed further progress on the development of a coronavirus vaccine but were hard-pressed to ignore rising infection rates and curbs on businesses that could hamper an economic recovery.

Contracts linked to the Dow Jones Industrial Average were up 197 points, S&P 500 futures gained 20 points and Nasdaq futures rose 43 points.

The Covid-19 vaccine candidate being developed by AstraZeneca  (AZN) – Get Report and the University of Oxford was found in a large trial to have prevented a majority of people from getting the disease.